Results 1 to 10 of about 573,829 (353)
Adjuvant Therapy: Melanoma [PDF]
Journal of Skin Cancer, 2011 With an incidence that is increasing at 2–5% per year, cutaneous melanoma is an international scourge that disproportionately targets young individuals. Despite much research, the treatment of advanced disease is still quite challenging.
Diwakar Davar +2 more
doaj +3 more sources
Vasculogenic mimicry triggers early recidivation and resistance to adjuvant therapy in esophageal cancer [PDF]
BMC CancerObjective To investigate the impact of vasculogenic mimicry (VM) and postoperative adjuvant therapy on the prognosis and survival of patients with esophageal squamous cell carcinoma (ESCC), as well as to assess whether VM affects the clinical benefit of ...
Jue Chen +5 more
doaj +2 more sources
Reliability of Reconstructed Breast Flap after Chemotherapy and Radiotherapy in Immediate Breast Reconstruction [PDF]
Archives of Plastic Surgery, 2012 Background Postmastectomy adjuvant therapy is used to prevent locoregional recurrence and improve overall breast cancer specific survival rates. However, it can adversely affect the cosmetic results of reconstruction.
Keun-Cheol Lee +10 more
doaj +2 more sources
Neoadjuvant and Adjuvant Therapy for Renal Cell Carcinoma
Société Internationale d’Urologie Journal, 2022 Patients undergoing definitive surgery or ablative techniques for nonmetastatic kidney cancer have varying degrees of risk of recurrent disease post procedure.
Naomi B. Haas +8 more
doaj +1 more source
Adjuvant therapy for HER2 positive pT1a-b pN0 breast cancer
Medicine, 2022 . Deciding if patients with small (≤1 cm), node-negative, human epidermal growth factor receptor 2 (HER2) positive breast cancer should receive adjuvant systemic therapy remains a challenge.
Xuan Yang, MM, Chong Xiao Qu, MD
doaj +1 more source
The Cancer Journal, 2016 In 2015, ramucirumab and TAS-102 became the 10th and 11th drugs approved by the Food and Drug administration for the treatment of patients with colorectal cancer, not counting leucovorin, and yet only 3 agents, 5-fluorouracil, capecitabine, and oxaliplatin, have proven benefit in adjuvant treatment.
Carling, Ursem +2 more
openaire +2 more sources
Adjuvant Dermatological Therapy
JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY, 2021 não ...
Sociedade Brasileira de TMO SBTMO +2 more
openaire +2 more sources
Frontiers in Oncology, 2023 BackgroundAlthough several clinical studies have laid the foundation for the adjuvant application of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), some questions remain unresolved.
Jun-Feng Liu +3 more
doaj +1 more source
Retrospective analysis of adjuvant treatment for localized, operable uterine leiomyosarcoma
Cancer Medicine, 2022 Objective Currently, there is no standard adjuvant treatment protocol for localized uterine leiomyosarcoma (uLMS) as clinical trials to address this question have been retrospective, underpowered, or undermined by slow accrual rates.
Jomjit Chantharasamee +11 more
doaj +1 more source